BRAD BRAZEAL: Open Payments
NPI 1265415640 · PALESTINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,980 in 122 payments from 13 companies in 2025. Trend: 2023 $2,702 · 2024 $2,172 · 2025 $2,980
Food & beverage: $2,688Consulting: $200Education: $91
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $516 |
| Teva Pharmaceuticals USA, Inc. | 15 | $353 |
| ABBVIE INC. | 17 | $298 |
| Axsome Therapeutics, Inc. | 10 | $277 |
| Neurocrine BioSciences, Inc. | 16 | $265 |
| Alkermes, Inc. | 7 | $217 |
| Lundbeck LLC | 14 | $211 |
| E.R. Squibb & Sons, L.L.C. | 7 | $200 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $186 |
Products named: REXULTI, VRAYLAR, SPRAVATO, Auvelity, INGREZZA, AUSTEDO XR, COBENFY, CAPLYTA.
Industry payments across TX — which companies pay providers there.
